A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome

Manoj Jangra, Dmitrii Y. Travin, Elena V. Aleksandrova, Manpreet Kaur, Lena Darwish, Kalinka Koteva, Dorota Klepacki, Wenliang Wang, Maya Tiffany, Akosiererem Sokaribo, Brian K. Coombes, Nora Vázquez-Laslop, Yury S. Polikanov (), Alexander S. Mankin () and Gerard D. Wright ()
Additional contact information
Manoj Jangra: McMaster University
Dmitrii Y. Travin: University of Illinois at Chicago
Elena V. Aleksandrova: University of Illinois at Chicago
Manpreet Kaur: McMaster University
Lena Darwish: McMaster University
Kalinka Koteva: McMaster University
Dorota Klepacki: University of Illinois at Chicago
Wenliang Wang: McMaster University
Maya Tiffany: McMaster University
Akosiererem Sokaribo: McMaster University
Brian K. Coombes: McMaster University
Nora Vázquez-Laslop: University of Illinois at Chicago
Yury S. Polikanov: University of Illinois at Chicago
Alexander S. Mankin: University of Illinois at Chicago
Gerard D. Wright: McMaster University

Nature, 2025, vol. 640, issue 8060, 1022-1030

Abstract: Abstract Lasso peptides (biologically active molecules with a distinct structurally constrained knotted fold) are natural products that belong to the class of ribosomally synthesized and post-translationally modified peptides1–3. Lasso peptides act on several bacterial targets4,5, but none have been reported to inhibit the ribosome, one of the main targets of antibiotics in the bacterial cell6,7. Here we report the identification and characterization of the lasso peptide antibiotic lariocidin and its internally cyclized derivative lariocidin B, produced by Paenibacillus sp. M2, which has broad-spectrum activity against a range of bacterial pathogens. We show that lariocidins inhibit bacterial growth by binding to the ribosome and interfering with protein synthesis. Structural, genetic and biochemical data show that lariocidins bind at a unique site in the small ribosomal subunit, where they interact with the 16S ribosomal RNA and aminoacyl-tRNA, inhibiting translocation and inducing miscoding. Lariocidin is unaffected by common resistance mechanisms, has a low propensity for generating spontaneous resistance, shows no toxicity to human cells, and has potent in vivo activity in a mouse model of Acinetobacter baumannii infection. Our identification of ribosome-targeting lasso peptides uncovers new routes towards the discovery of alternative protein-synthesis inhibitors and offers a novel chemical scaffold for the development of much-needed antibacterial drugs.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-025-08723-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:640:y:2025:i:8060:d:10.1038_s41586-025-08723-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-025-08723-7

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().